Postnatal Depression: Clinical Features & the Edinburgh Postnatal Depression Scale (EPDS)

Overview

Clinical Features of Postnatal Depression

A. Core Depressive Symptoms

• Persistent low mood — prolonged sadness, tearfulness, emotional numbness
• Anhedonia — loss of pleasure in activities, including loss of joy in the baby
• Fatigue and anergia — severe tiredness disproportionate to sleep disruption
• Sleep disturbance — insomnia (particularly early-morning waking) or hypersomnia, distinct from infant-related sleep loss
• Appetite changes — decreased or increased appetite; weight changes
• Psychomotor changes — retardation or agitation observable by others
• Cognitive impairment — poor concentration, forgetfulness, indecisiveness ("brain fog")
• Feelings of worthlessness or excessive guilt
• Suicidal ideation — passive (wishing to be dead) or active; requires urgent assessment

B. PND-Specific Features (Differentiating from Non-Postpartum Depression)

C. Physical Symptoms

• Unexplained somatic complaints (headaches, palpitations, chest tightness)
• Reduced libido
• Neglect of personal hygiene or self-care

D. Risk Factors (Aid Early Recognition)

The Edinburgh Postnatal Depression Scale (EPDS)

Background

Structure

Item 10 is critical — any score > 0 on this item requires immediate clinical follow-up regardless of total score.

Scoring and Cut-offs

• The scale is validated in multiple languages and cross-cultural settings.
• Takes < 5 minutes to complete, making it practical in primary care and health visiting contexts.

Role in Early Diagnosis

1. Initial antenatal visit — to establish baseline and identify pre-existing depression
2. 4–6 weeks postpartum — first postnatal review (common UK/NICE recommendation)
3. 3–4 months postpartum — second screening point, as PND may emerge later

Why the EPDS is Particularly Valuable for Early Detection:

Limitations

• Not diagnostic — a high EPDS score must be followed by a full clinical interview (DSM-5/ICD criteria)
• Relies on honest self-reporting — women may underreport due to fear of infant removal or stigma
• May miss atypical presentations — severe irritability/anger without sadness can score low
• Does not assess psychosis — hallucinations or delusions require separate clinical assessment
• Language and literacy barriers — must be administered in the patient's first language with appropriate reading support

Clinical Pathway: Using EPDS in Practice

Administer EPDS (antenatal visit, 6 weeks, 3 months postpartum)
        │
        ▼
Score ≥ 13 ──────────────────────────────────────────────────────►  Full psychiatric assessment
        │                                                              + safety plan
Score 10–12 ──────────────────────────────────────────────────────►  Clinical interview + review in 2 weeks
        │                                                              + increased support
Score < 10 ───────────────────────────────────────────────────────►  Reassure + routine review
        │
Item 10 > 0 (any score) ─────────────────────────────────────────►  IMMEDIATE risk assessment

Management Overview (Once Diagnosed)

Key Points

• PND presents with classic depressive symptoms plus postpartum-specific features including impaired bonding, intrusive thoughts, and excessive infant-focused anxiety.
• The EPDS is the gold standard screening instrument for PND, validated since 1987, and captures both depressive and anxiety dimensions while avoiding somatic overlap.
• Screening at multiple time points (antenatal, 6 weeks, 3 months) is essential as PND does not always present immediately after birth.
• A high EPDS score is a trigger for clinical assessment, not a diagnosis in itself — the goal is early identification and intervention to protect both maternal health and infant development.
• Untreated PND is associated with impaired mother-infant attachment, adverse infant cognitive and emotional development, and increased risk of chronic maternal depression.